Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotic Disorders | 5 | 2022 | 135 | 2.350 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2022 | 328 | 1.890 |
Why?
|
| Child Abuse | 3 | 2019 | 82 | 1.580 |
Why?
|
| Psychiatry | 2 | 2017 | 117 | 0.910 |
Why?
|
| Physician-Patient Relations | 2 | 2017 | 360 | 0.840 |
Why?
|
| Child Psychiatry | 1 | 2022 | 38 | 0.820 |
Why?
|
| Patients | 1 | 2022 | 87 | 0.800 |
Why?
|
| Schizophrenia | 3 | 2019 | 214 | 0.800 |
Why?
|
| Infant, Extremely Premature | 2 | 2021 | 32 | 0.790 |
Why?
|
| Academic Performance | 1 | 2019 | 6 | 0.750 |
Why?
|
| Education, Special | 1 | 2019 | 11 | 0.750 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2019 | 10 | 0.740 |
Why?
|
| Psychological Trauma | 1 | 2019 | 22 | 0.710 |
Why?
|
| Referral and Consultation | 1 | 2022 | 358 | 0.680 |
Why?
|
| Mental Health Services | 1 | 2022 | 270 | 0.660 |
Why?
|
| Clinical Clerkship | 1 | 2017 | 75 | 0.600 |
Why?
|
| Child | 10 | 2022 | 3870 | 0.570 |
Why?
|
| Comorbidity | 3 | 2019 | 999 | 0.560 |
Why?
|
| Students, Medical | 1 | 2017 | 220 | 0.510 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2014 | 18 | 0.500 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2013 | 11 | 0.480 |
Why?
|
| Child Development | 1 | 2014 | 78 | 0.470 |
Why?
|
| Life Change Events | 1 | 2013 | 67 | 0.460 |
Why?
|
| Mental Disorders | 1 | 2019 | 669 | 0.450 |
Why?
|
| Emotions | 1 | 2014 | 196 | 0.430 |
Why?
|
| Adolescent | 8 | 2022 | 5331 | 0.420 |
Why?
|
| Aggression | 1 | 2012 | 60 | 0.420 |
Why?
|
| Violence | 1 | 2012 | 153 | 0.370 |
Why?
|
| Antipsychotic Agents | 2 | 2008 | 282 | 0.340 |
Why?
|
| Bupropion | 1 | 2008 | 8 | 0.340 |
Why?
|
| Serotonin Syndrome | 1 | 2008 | 8 | 0.340 |
Why?
|
| Cyclohexanols | 1 | 2008 | 17 | 0.340 |
Why?
|
| Fluoxetine | 1 | 2008 | 43 | 0.330 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2008 | 25 | 0.330 |
Why?
|
| Benzodiazepines | 1 | 2008 | 84 | 0.320 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2008 | 60 | 0.320 |
Why?
|
| Methadone | 1 | 2008 | 94 | 0.310 |
Why?
|
| Anxiety Disorders | 1 | 2008 | 165 | 0.290 |
Why?
|
| Depressive Disorder | 1 | 2008 | 266 | 0.270 |
Why?
|
| Humans | 14 | 2022 | 50630 | 0.270 |
Why?
|
| Young Adult | 3 | 2022 | 3731 | 0.270 |
Why?
|
| Internship and Residency | 1 | 2012 | 616 | 0.270 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 2295 | 0.250 |
Why?
|
| Opioid-Related Disorders | 1 | 2008 | 350 | 0.220 |
Why?
|
| Child Behavior Disorders | 1 | 2021 | 42 | 0.200 |
Why?
|
| Female | 7 | 2022 | 26606 | 0.200 |
Why?
|
| Male | 6 | 2022 | 23331 | 0.190 |
Why?
|
| Gestational Age | 1 | 2019 | 172 | 0.180 |
Why?
|
| Risk Factors | 2 | 2022 | 4352 | 0.170 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 376 | 0.160 |
Why?
|
| Infant | 1 | 2022 | 1415 | 0.150 |
Why?
|
| Child, Preschool | 1 | 2022 | 1685 | 0.150 |
Why?
|
| Massachusetts | 1 | 2022 | 1997 | 0.140 |
Why?
|
| Adult | 3 | 2019 | 13414 | 0.140 |
Why?
|
| Schizophrenic Psychology | 2 | 2013 | 50 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2196 | 0.130 |
Why?
|
| Cholecalciferol | 1 | 2015 | 24 | 0.130 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 56 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1945 | 0.130 |
Why?
|
| Depression | 1 | 2021 | 765 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2017 | 774 | 0.130 |
Why?
|
| United States | 2 | 2019 | 6435 | 0.120 |
Why?
|
| Parental Death | 1 | 2013 | 3 | 0.120 |
Why?
|
| Bullying | 1 | 2013 | 10 | 0.120 |
Why?
|
| Hallucinations | 1 | 2013 | 16 | 0.120 |
Why?
|
| Communication | 1 | 2017 | 473 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2015 | 214 | 0.110 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 51 | 0.110 |
Why?
|
| Bipolar Disorder | 1 | 2015 | 244 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2012 | 233 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 369 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2012 | 201 | 0.100 |
Why?
|
| Age Factors | 1 | 2013 | 1409 | 0.090 |
Why?
|
| Middle Aged | 2 | 2019 | 13531 | 0.090 |
Why?
|
| Social Support | 1 | 2012 | 339 | 0.090 |
Why?
|
| Venlafaxine Hydrochloride | 1 | 2008 | 15 | 0.080 |
Why?
|
| Prevalence | 1 | 2012 | 1130 | 0.080 |
Why?
|
| Delayed-Action Preparations | 1 | 2008 | 99 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 358 | 0.080 |
Why?
|
| Aged | 1 | 2019 | 10999 | 0.070 |
Why?
|
| Age of Onset | 2 | 2013 | 149 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2013 | 738 | 0.040 |
Why?
|
| Anxiety | 1 | 2021 | 343 | 0.040 |
Why?
|
| Parents | 1 | 2021 | 331 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 1196 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 73 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2015 | 92 | 0.030 |
Why?
|
| Affect | 1 | 2015 | 114 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 2590 | 0.030 |
Why?
|
| Communication Disorders | 1 | 2013 | 8 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2013 | 119 | 0.030 |
Why?
|
| Child Behavior | 1 | 2013 | 61 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2013 | 154 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 3952 | 0.020 |
Why?
|